Insights

Innomar Strategies

Meet the Expert: Matthew Nelson

Innomar Strategies

April 2026

Manufacturers

The value of Real-World Evidence in Canadian drug commercialization: Part 2

Innomar Strategies

April 2021

Manufacturers

Uncover growth opportunities in niche Canadian pharma markets. Innomar Strategies shares strategic insights to help specialty pharma brands expand their reach.

Nurse-led Health Case Management

Innomar Strategies

Meet the Expert: Matthew Nelson

The value of Real-World Evidence in Canadian drug commercialization: Part 2

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Improved Health Outcomes in Patients Receiving Health Case Management

Case Study: Discovering New Opportunities for Growth in a Niche Market

Nurse-led Health Case Management

Explore More by Topic

Affordability

Analytics

Biosimilars

Commercialization

COVID-19

Data